PDCD1 and neoplasm: In an orthotopic murine model of renal cell carcinoma that develops lung metastases, VTP in combination with anti-PD-1/PD-L-1 antibodies demonstrates superior anti-tumor activity as compared to checkpoint blockade alone and induces immune infiltration in primary and metastatic sites (16).